BMY News and Press, Bristol-Myers Squibb Company From 05/21/24

2024-05-21 08:15:06 ET Citigroup analyst issues BUY recommendation for BMY on May 21, 2024 06:22AM ET. The previous analyst recommendation was Buy. BMY was trading at $43.36 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst...

2024-05-21 08:15:00 ET There are many positive things about Bristol Myers Squibb (NYSE: BMY) and its stock. It has a decently high dividend yield, it's one of the world's largest pharmaceutical companies, and it makes dozens and dozens of life-saving medications, with even more to c...

2024-05-21 07:29:59 ET More on Bristol-Myers Squibb Bristol-Myers Squibb Company (BMY) Bank of America Global Healthcare Conference 2024 Transcript Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript) Bristol-Myer...

Updated Prescription Drug User Fee Act (PDUFA) goal date of December 29, 2024 Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has reassigned the previously announced Prescription Drug User Fee Act (PDUFA) goal date of the Biolo...

2024-05-19 15:05:03 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety The FTC Cracks Down On Novo Nordisk's Ozempic Biopharma M&A surges year ...

2024-05-18 14:52:07 ET More on GSK, Johnson & Johnson, etc. Shockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson Investors Merck & Co., Inc. (MRK) BofA Securities 2024 Health Care Conference (Transcript) Johnson & Johnson (JNJ) ...

2024-05-17 14:09:29 ET Summary Dividend growth stocks can provide reliable cash flows and help to build long-term wealth for income investors. Every month we look at screening dividend stocks based on safety, growth, and consistency, which can help identify worthwhile investments....

Following four years of continuous Sotyktu treatment, clinical response was maintained in more than seven out of 10 patients for Psoriasis Area and Severity Index (PASI) 75 in the POETYK PSO long-term extension trial No new safety signals observed at Year 4 in the POETYK PSO long-...

2024-05-16 07:33:31 ET In a recent 13F filing, Tudor Investment Corp., the investment firm founded by legendary trader Paul Tudor Jones revealed initiating a stake in PayPal Holdings Inc. (NASDAQ:PYPL), acquiring approximately 888,239 shares valued at $59.5 million during the first quar...

95.7% of patients responded to Breyanzi in the TRANSCEND FL trial Breyanzi provided sustained clinical benefit with median duration of response not reached and the majority (77.1%) of responders in ongoing response at 18 months Breyanzi is a personalized therapy with a...